Shanghai Historical Income Statement

603579 Stock

14.14 0.19 1.36%

Historical analysis of Shanghai Rongtai income statement accounts such as Selling General Administrative of 212.2 M, Total Revenue of 1.6 B or Operating Income of 192.8 M can show how well Shanghai Rongtai Health performed in making a profits. Evaluating Shanghai Rongtai income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Shanghai Rongtai's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Shanghai Rongtai Health latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Shanghai Rongtai Health is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Shanghai Income Statement Analysis

Shanghai Rongtai Health Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Shanghai Rongtai shareholders. The income statement also shows Shanghai investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Shanghai Rongtai Income Statement Chart

At present, Shanghai Rongtai's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 212.2 M, whereas Total Revenue is forecasted to decline to about 1.6 B.

Selling General Administrative Total Revenue Operating Income Research Development

Total Revenue

Total revenue comprises all receipts Shanghai Rongtai Health generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Operating Income

Operating Income is the amount of profit realized from Shanghai Rongtai Health operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Shanghai Rongtai Health is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Most accounts from Shanghai Rongtai's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Shanghai Rongtai Health current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2022	2023	2024	2025 (projected)
Operating Income	171.1M	215.7M	248.1M	192.8M
Total Revenue	2.0B	1.9B	2.1B	1.6B

Operating Income Total Revenue

Shanghai Rongtai income statement Correlations

	Selling General Administrative	Total Revenue	Operating Income	Research Development	Cost Of Revenue	Income Before Tax	Income Tax Expense	Minority Interest	Tax Provision	Net Interest Income	Interest Income	Gross Profit	Other Operating Expenses	Net Income From Continuing Ops	Ebit	Total Operating Expenses	Net Income	Ebitda	Reconciled Depreciation
Selling General Administrative		0.91	0.94	0.94	0.88	0.91	0.86	0.51	-0.14	-0.17	0.31	0.82	0.47	0.33	-0.03	0.8	0.36	0.25	0.59
Total Revenue	0.91		0.94	0.99	0.99	0.93	0.89	0.26	-0.33	-0.08	0.51	0.73	0.73	0.19	-0.34	0.92	0.26	0.04	0.55
Operating Income	0.94	0.94		0.96	0.9	0.98	0.91	0.4	-0.17	0.01	0.41	0.77	0.54	0.3	-0.14	0.79	0.35	0.12	0.51
Research Development	0.94	0.99	0.96		0.98	0.93	0.87	0.29	-0.26	-0.08	0.44	0.79	0.63	0.28	-0.23	0.91	0.35	0.12	0.54
Cost Of Revenue	0.88	0.99	0.9	0.98		0.89	0.86	0.19	-0.37	-0.11	0.52	0.7	0.76	0.15	-0.38	0.94	0.23	0.01	0.54
Income Before Tax	0.91	0.93	0.98	0.93	0.89		0.96	0.37	-0.12	0.04	0.44	0.7	0.56	0.33	-0.2	0.77	0.37	0.14	0.51
Income Tax Expense	0.86	0.89	0.91	0.87	0.86	0.96		0.38	-0.19	0.1	0.54	0.58	0.63	0.21	-0.35	0.72	0.23	0.04	0.47
Minority Interest	0.51	0.26	0.4	0.29	0.19	0.37	0.38		0.49	-0.33	-0.15	0.61	-0.18	0.51	0.46	0.17	0.41	0.54	0.35
Tax Provision	-0.14	-0.33	-0.17	-0.26	-0.37	-0.12	-0.19	0.49		-0.3	-0.59	0.19	-0.64	0.79	0.75	-0.35	0.72	0.79	0.1
Net Interest Income	-0.17	-0.08	0.01	-0.08	-0.11	0.04	0.1	-0.33	-0.3		0.62	-0.35	0.16	-0.36	-0.48	-0.1	-0.39	-0.63	-0.43
Interest Income	0.31	0.51	0.41	0.44	0.52	0.44	0.54	-0.15	-0.59	0.62		0.02	0.78	-0.42	-0.83	0.58	-0.39	-0.6	0.05
Gross Profit	0.82	0.73	0.77	0.79	0.7	0.7	0.58	0.61	0.19	-0.35	0.02		0.26	0.67	0.29	0.69	0.68	0.57	0.72
Other Operating Expenses	0.47	0.73	0.54	0.63	0.76	0.56	0.63	-0.18	-0.64	0.16	0.78	0.26		-0.27	-0.8	0.75	-0.2	-0.39	0.46
Net Income From Continuing Ops	0.33	0.19	0.3	0.28	0.15	0.33	0.21	0.51	0.79	-0.36	-0.42	0.67	-0.27		0.65	0.15	0.99	0.92	0.52
Ebit	-0.03	-0.34	-0.14	-0.23	-0.38	-0.2	-0.35	0.46	0.75	-0.48	-0.83	0.29	-0.8	0.65		-0.36	0.6	0.78	0.11
Total Operating Expenses	0.8	0.92	0.79	0.91	0.94	0.77	0.72	0.17	-0.35	-0.1	0.58	0.69	0.75	0.15	-0.36		0.24	0.04	0.55
Net Income	0.36	0.26	0.35	0.35	0.23	0.37	0.23	0.41	0.72	-0.39	-0.39	0.68	-0.2	0.99	0.6	0.24		0.89	0.53
Ebitda	0.25	0.04	0.12	0.12	0.01	0.14	0.04	0.54	0.79	-0.63	-0.6	0.57	-0.39	0.92	0.78	0.04	0.89		0.54
Reconciled Depreciation	0.59	0.55	0.51	0.54	0.54	0.51	0.47	0.35	0.1	-0.43	0.05	0.72	0.46	0.52	0.11	0.55	0.53	0.54

Click cells to compare fundamentals

Shanghai Rongtai Account Relationship Matchups

Shanghai Rongtai income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Interest Expense	6.8M	28.7M	28.8M	27.4M	31.5M	33.1M
Selling General Administrative	203.9M	276.5M	226.9M	174.4M	200.5M	212.2M
Total Revenue	2.0B	2.6B	2.0B	1.9B	2.1B	1.6B
Operating Income	243.5M	264.3M	171.1M	215.7M	248.1M	192.8M
Research Development	100.1M	119.2M	88.7M	80.2M	92.2M	78.3M
Cost Of Revenue	1.4B	1.9B	1.5B	1.3B	1.5B	1.1B
Income Before Tax	198.2M	261.0M	179.4M	230.2M	264.7M	192.6M
Income Tax Expense	31.9M	39.6M	17.2M	32.9M	37.9M	24.9M
Minority Interest	(9.1M)	8.3M	(491.9K)	(625.1K)	(562.6K)	(534.4K)
Tax Provision	17.2M	32.9M	14.7M	26.9M	24.2M	23.0M
Net Interest Income	(1.1M)	(20.7M)	(4.3M)	7.0M	8.0M	8.4M
Interest Income	7.6M	10.0M	24.8M	34.8M	40.1M	42.1M
Gross Profit	579.9M	701.1M	531.8M	571.8M	514.6M	511.4M
Other Operating Expenses	4.2M	5.2M	6.3M	7.8M	9.0M	5.5M
Net Income From Continuing Ops	181.0M	228.0M	164.7M	203.3M	183.0M	175.1M
Ebit	275.2M	221.8M	239.5M	146.1M	131.5M	199.3M
Total Operating Expenses	1.8B	2.3B	1.8B	1.6B	1.9B	2.0B
Net Income Applicable To Common Shares	295.6M	193.0M	236.3M	164.2M	147.8M	178.4M
Net Income	193.0M	236.3M	164.2M	202.7M	182.4M	176.4M
Ebitda	397.0M	252.2M	352.5M	267.1M	240.4M	262.5M
Reconciled Depreciation	47.1M	62.8M	58.9M	60.0M	54.0M	49.5M

Currently Active Assets on Macroaxis

V	Visa Class A
GM	General Motors
C	Citigroup
BAC	Bank of America
DD	Dupont De Nemours

Other Information on Investing in Shanghai Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Shanghai Historical Income Statement

About Shanghai Income Statement Analysis

Shanghai Rongtai Income Statement Chart

Total Revenue

Operating Income

Shanghai Rongtai income statement Correlations

Shanghai Rongtai Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Shanghai Rongtai income statement Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Shanghai Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Research Development	+ 0.99	Total Revenue
Cost Of Revenue	+ 0.99	Total Revenue
Net Income	+ 0.99	Net Income From Continuing Ops
Income Before Tax	+ 0.98	Operating Income
Cost Of Revenue	+ 0.98	Research Development
Research Development	+ 0.96	Operating Income

Ebit	- 0.83	Interest Income
Ebit	- 0.8	Other Operating Expenses
Other Operating Expenses	- 0.64	Tax Provision
Ebitda	- 0.63	Net Interest Income
Ebitda	- 0.6	Interest Income
Interest Income	- 0.59	Tax Provision